CD8A and type 1 diabetes mellitus: Interestingly, it is also recognized that (i) 60-70% of patients with T1DM have islet infiltrating preproinsulin (PPI)-reactive CD8+ T-cells and (ii) in vitro analysis has revealed that PPI-reactive CD8+ T-cells may destroy human β-cells (90).